Table 1.

TRPC3 expression levels correlate with the prognosis of ovarian cancer patients (total 90 cases of ovarian cancer and 63 cases of serous ovarian cancer)

A. The association with disease free survival between each of parameters
	Total cases				Serous type
			95.0% CI for HR				95.0% CI for HR
	P	HR	Lower	Upper	P	HR	Lower	Upper
Age	0.238	1.015	0.990	1.041	0.389	1.015	0.981	1.050
TRPC3 expression	0.003	2.802	1.406	5.586	0.001	4.073	1.753	9.462
Clinical stage	<0.001	6.795	2.985	15.465	0.001	7.069	2.136	23.392
Lymphatic metastasis	<0.001	5.358	2.746	10.457	0.001	3.828	1.754	8.354
Grade	0.002	1.927	1.278	2.905	0.034	1.691	1.041	2.747

B. The association with overall survival between each of parameters
	Total cases				Serous type
			95.0% CI for HR				95.0% CI for HR
	P	HR	Lower	Upper	P	HR	Lower	Upper
Age	0.228	1.022	0.986	1.059	0.443	1.019	0.972	1.068
TRPC3 expression	0.039	2.866	1.056	7.777	0.039	3.766	1.073	13.226
Clinical stage	0.015	11.977	1.604	89.429	0.034	8.911	1.174	67.668
Lymphatic metastasis	<0.001	11.616	3.426	39.383	0.005	8.540	1.936	37.680
Grade	<0.001	11.616	3.426	39.383	0.137	1.695	0.845	3.398

HR: hazard ratio; CI: confidential interval